Corrigendum to "Rechallenge with BRAF-directed treatment in metastatic melanoma: A multi-institutional retrospective study*" [Eur J Cancer 91 (2018) 116-124].
Authors
Valpione, SaraCarlino, M
Mangana, J
Mooradian, M
McArthur, G
Schadendorf, D
Hauschild, A
Menzies, A
Arance, A
Ascierto, P
Giacomo, A
de Rosa, F
Larkin, J
Park, J
Goldinger, S
Sullivan, R
Xu, W
Livingstone, E
Weichenthal, M
Rai, R
Gaba, L
Long, G
Lorigan, Paul C
Affiliation
The Christie NHS Foundation Trust, University of Manchester, Manchester, UKIssue Date
2018-04
Metadata
Show full item recordCitation
Corrigendum to "Rechallenge with BRAF-directed treatment in metastatic melanoma: A multi-institutional retrospective study*" [Eur J Cancer 91 (2018) 116-124]. 2018, 93:158 Eur J CancerJournal
European journal of CancerDOI
10.1016/j.ejca.2018.02.001PubMed ID
29548533Type
ArticleLanguage
enISSN
1879-0852ae974a485f413a2113503eed53cd6c53
10.1016/j.ejca.2018.02.001
Scopus Count
Collections
Related articles
- Rechallenge with BRAF-directed treatment in metastatic melanoma: A multi-institutional retrospective study.
- Authors: Valpione S, Carlino MS, Mangana J, Mooradian MJ, McArthur G, Schadendorf D, Hauschild A, Menzies AM, Arance A, Ascierto PA, Di Giacomo A, de Rosa F, Larkin J, Park JJ, Goldinger SM, Sullivan RJ, Xu W, Livingstone E, Weichenthal M, Rai R, Gaba L, Long GV, Lorigan P
- Issue date: 2018 Mar
- BRAF and MEK inhibitors rechallenge as effective treatment for patients with metastatic melanoma.
- Authors: Cybulska-Stopa B, Rogala P, Czarnecka AM, Galus Ł, Dziura R, Rajczykowski M, Kubiatowski T, Wiśniewska M, Gęga-Czarnota A, Teterycz P, Ziobro M, Suwiński R, Mackiewicz J, Rutkowski P
- Issue date: 2020 Oct
- The concepts of rechallenge and retreatment in melanoma: A proposal for consensus definitions.
- Authors: Gebhardt C, Ascierto P, Atkinson V, Corrie P, Dummer R, Schadendorf D
- Issue date: 2020 Oct
- Discontinuation of BRAF/MEK-Directed Targeted Therapy after Complete Remission of Metastatic Melanoma-A Retrospective Multicenter ADOReg Study.
- Authors: Stege H, Haist M, Schultheis M, Fleischer MI, Mohr P, Meier F, Schadendorf D, Ugurel S, Livingstone E, Zimmer L, Herbst R, Pföhler C, Kähler K, Weichenthal M, Terheyden P, Nashan D, Debus D, Kaatz M, Ziller F, Haferkamp S, Forschner A, Leiter U, Kreuter A, Ulrich J, Kleemann J, Bradfisch F, Grabbe S, Loquai C
- Issue date: 2021 May 12
- Efficacy of rechallenge with BRAF inhibition therapy in patients with advanced BRAFV600 mutant melanoma.
- Authors: Viñal D, Martinez D, Espinosa E
- Issue date: 2019 Aug